Mylan launches world’s first trastuzumab biosimilar
MUMBAI and PITTSBURGH — Mylan on Monday announced that its subsidiary, Mylan Pharmaceuticals Private Limited, has launched the world’s first trastuzumab biosimilar in India. The product — which will be marketed by Mylan as Hertraz — is used for the treatment of HER2-positive metastatic breast cancer. Hertraz is a biosimilar to Roche’s Herceptin and is available in two strengths: 440mg and 150mg.
"Mylan is excited to offer Hertraz to the thousands of women in India suffering from metastatic breast cancer who are in need of a high quality, more affordable treatment option," Mylan CEO Heather Bresch, said. "The launch of Hertraz not only represents a significant milestone in our biosimilars development program with Biocon, but, more importantly, supports our mission to expand access to high quality medicine around the world and demonstrates our progress against one of Mylan’s key future growth drivers.”
According to IPSOS, trastuzumab had sales in India of approximately $21 million for the 12 months ended Dec. 31, 2012.
NCPA: Independent pharmacies rate high in Consumer Reports survey
ALEXANDRIA, Va. — The National Community Pharmacists Association has highlighted a recent Consumer Reports magazine survey, which gave independent community pharmacies high marks for overall customer satisfaction and the best ratings of any pharmacy provider in such categories as “speed and accuracy”; “courtesy and helpfulness”; and “pharmacists’ knowledge.”
According to the publication’s pharmacy survey featured in the March 2014 issue of the magazine, patients at independent pharmacies reported shorter wait times and a greater likelihood that independents would have medication in stock, compared to some other pharmacy options.
“Patients come first for independent community pharmacists and it’s encouraging to see that their efforts are noted and appreciated in this survey,” stated NCPA CEO B. Douglas Hoey, who is also quoted in the article. “We congratulate America’s independent pharmacists on this milestone and look forward to continuing to support their efforts to support medication adherence, improve patient health and reduce overall health costs.”
The NCPA noted that independent community pharmacies are consistently recognized in national consumer surveys for their customer service. Locally owned and operated franchisees of Good Neighbor Pharmacy Health Mart and The Medicine Shoppe received the highest customer satisfaction rating from patients in their category of the J.D. Power 2013 Pharmacy Study. In addition, the Pharmacy Satisfaction patient survey sponsored by Boehringer Ingelheim Pharmaceuticals reported similar findings.
Hy-Vee to offer flu, strep tests as part of study
NEW YORK — Hy-Vee has teamed up with the University of Nebraska Medical Center College of Pharmacy and Ferris State University to offer rapid-diagnostic flu and strep tests in its pharmacies.
Hy-Vee stores in Omaha and Papillion are among 60 sites throughout three states that will have pharmacists trained to administer these tests, the results of which are available shortly after the test is given. In addition to the testing, pharmacists also will be able to fill prescriptions to treat identified illnesses, if needed, under protocol set by prescribing physicians.
The tests are part of a research study conducted by UNMC and Ferris State and are available to Hy-Vee customers who qualify for the program. Participants must be at least 19 years of age and exhibit symptoms consistent with influenza or strep.
“At Hy-Vee we are committed to the health and wellness of our customers and communities,” Bob Egeland, VP of pharmacy at Hy-Vee said. “Our pharmacists have long had the job of helping our customers get well and make educated choices in their treatments. This is just another way that we can improve our level of customer service and save people time and money when the situation warrants.”
Also collaborating with Ferris State University and the University of Nebraska Medical Center College of Pharmacy is Meijer. As previously reported by Drug Store News, the mass-merchandise chain announced earlier this month that its pharmacy locations in Michigan would be participating in the study and offering free testing for flu and strep throat.